Suchergebnisse - "Kang, Yoon-Koo"

PubPharm (94)

1

Ripretinib versus sunitinib in gastrointestinal stromal tumor : ctDNA biomarker analysis of the phase 3 INTRIGUE trial

enthalten in: Nature medicine | 2024

von Heinrich, M. | Jones, R. | George, S. | +26

2

Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Kong, S. | Kurokawa, Y. | Yook, J. | +17

3

A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours

enthalten in: British journal of cancer | 2023

von Kim, H. | Yoo, C. | Ryu, M. | +1

4

Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Kang, Y. | Kim, H. | Kim, H. | +3

5

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE) : A Randomized, Open-Label, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Bauer, S. | Jones, R. | Blay, J. | +16

CommentIn: J Clin Oncol. 2022 Dec 1;40(34):3903-3906. - PMID 36054848

6

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers : a phase 1, dose-escalation and expansion study

enthalten in: The Lancet. Oncology | 2022

von Meric-Bernstam, F. | Beeram, M. | Hamilton, E. | +20

7

Clinical outcomes and prognostic factors for patients with high-risk gastrointestinal stromal tumors treated with 3-year adjuvant imatinib

enthalten in: International journal of cancer | 2022

von Bang, Y. | Ryu, M. | Kim, H. | +2

8

Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor : A Retrospective Analysis

enthalten in: Cancer research and treatment | 2022

von Kang, S. | Ryu, M. | Bang, Y. | +3

9

Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor : A Randomized, Open-Label Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Kang, Y. | George, S. | Jones, R. | +19

10

Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period : Impact of Anti-HER2-Targeted Agent in the Real-World Setting

enthalten in: Cancer research and treatment | 2021

von Koo, D. | Ryu, M. | Lee, M. | +4

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]